A Study Of GLP-1 Receptor Agonists On Reproductive Health In Women

Overview

About this study

The purpose of this study is explore the way GLP-1 agonists affect reproductive health and the way in which this may be happening, with focus on sexual health, menstruation, and fertility. To understand prevalence of contraceptive use and contraceptive failure in women using GLP-1 agonists during their reproductive years. To understand the efficacy each available GLP-1 agonist or dual agonist may have on reproductive health.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Utilize Mayo’s MyChart patient portal, enrolled in the Mayo Clinic healthcare system, speak English, identified as female gender, has heterosexual relationships, on GLP-1 medication, age 18-55.

Exclusion Criteria:

  • Post-menopausal women, all other genders other than identified as female, non-English speakers or readers, cognitive challenges where the participant was unable to complete the survey.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/17/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Suneela Vegunta

Open for enrollment

Contact information:

Suneela Vegunta

(480) 614-6001

vegunta.suneela@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597465

Mayo Clinic Footer